InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...
After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If finalized as proposed, FDA would ...
1d
Evexia Diagnostics Expands At-Home Testing Capabilities with the Addition of Biobox™ by Access Labs
New at-home blood collection solution helps clinicians increase patient compliance, expand access to testing, and ...
Food testing laboratories are facing increasing pressure to deliver fast, reliable, and defensible results across complex matrices. Expanding pesticide panels, stricter regulatory expectations, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results